amarininvestor, My source believes a deal will happen, his main concern
is what would be the price agreed to. Like any other rumour, treat it
as just that. My own view is that JT's comments hint that Europe is
a massive market that needs a large sales force. Would a BO make sense
for a BP that wants to make develop the Europe market in a big way? Sure!
An interested BP would be in a much better position to turn Vascepa
into the winning medication it should be. If JT were to actually GIA
it would be corporate suicide. By now our esteemed BOD should understand
this by now. Assuming a BO is under consideration, the sooner one is
consummated, the larger the amount of money that could be made...
especially on the back end. For example, if BP has 10 years to
promote Vascepa in Europe with zero competition, year 10 revenues
may be over $5 billion...shave one year off and that could be very
costly.
News 
Market Data 
Discover 
